Syngenta in Deal with Novozymes to Sell Biofungicide
30 October 2012 Syngenta said it signed a deal with Novozymes to commercialize Taegro, a fermented biological fungicide based on a naturally occurring bacterium Bacillus subtilis. It offers growers broad-spectrum disease control at very low application rates in a variety of crops. Its multiple modes of action complement Syngenta’s extensive fungicide portfolio.
In April, Syngenta and Novozymes signed a global agreement to commercialize the Novozymes technology JumpStart, a seed-applied biological that increases phosphate solubility in the soil.
Chief Operating Officer John Atkin said, “Having worldwide commercial rights for Taegro will further strengthen our ability to offer high-performing integrated crop solutions.”
Thomas Videbæk, Executive Vice President Novozymes, commented: “This collaboration matches Syngenta’s global market strength and leading position within fungicides and integrated solutions with Novozymes’ deep know-how on sustainable, bio-based technologies.”
Expanding the existing registrations of Taegro in the United States, the companies aim to offer the technology to growers worldwide for use on a broad range of crops.
Financial details about the agreement were not disclosed.
Source: Syngenta; edited by FCI staff
Get The Newsletter Today!
